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The widespread use of antibiotics to eliminate pathogenic microorganisms is currently under 
pressure, due to the alarming emergence of antibiotic resistance. This has forced scientists 
to widen their scope in the search for alternatives, and has drawn the attention to 
bacteriophage (phage) as new bactericidal entities. Phages are viruses that highly 
specifically recognize and infect bacteria. After invasion and multiplication of the host, phage 
can turn lytic by hydrolyzing the host´s cell wall, using (endo)lysins. Lysins are hydrolytic 
enzymes that generally consist of two domains: a catalytic domain (e.g. N-terminal) and a C-
terminal cell binding domain (CBD) that binds to a specific sugar molecule on the cell wall. 
The idea of using lysins as stand-alone active compounds has only been considered since 
recently [1]. Several reports show that the external addition of lysins to Gram-positive 
pathogens (Bacillus anthracis, Streptococci) results in an effective in vivo elimination of the 
organism, similar to the extent whole phages would kill them [2]. This demonstrates that 
purified lysins from phages serve efficiently as antimicrobials.  
The access to a range of lytic bacteriophages and new phage isolates active against several 
pathogens has allowed us to screen their genomes and select for endolysins. Some were 
heterologously produced and purified, showing a similar activity range as their corresponding 
phages. Moreover, we are currently isolating endolysins from phages active against Gram-
negative bacteria and developing strategies to apply them directly, without the need of 
pretreatment of the host´s outer membrane.  
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